M. M. Suzman, M.D., F.R.C.P.
This content is PDF only. Please click on the PDF icon to access.
Forty patients, presenting with symptoms of anxiety of 1 month to 35 years' duration, were studied before and during the administration of propranolol in the total daily dose of 40 to 160 mg, as well as during placebo substitution, for periods varying from 1 to 40 months.
Before treatment, while in the upright position and to a greater extent during voluntary hyperventilation, they invariably exhibited an increase in severity of the symptoms with acceleration of the heart rate, and in 14 patients there was also induction or accentuation of ST segment depression, or T wave inversion, or both, abolished promptly
Learn more about subscription options.
Register Now for a free account.
Suzman MM. An Evaluation of the Effects of Propranolol on the Symptoms and Electrocardiographic Changes in Patients with Anxiety and the Hyperventilation Syndrome.. Ann Intern Med. 1968;68:1194. doi: 10.7326/0003-4819-68-5-1194_1
Download citation file:
Published: Ann Intern Med. 1968;68(5):1194.
Cardiac Diagnosis and Imaging, Cardiology, Coronary Risk Factors, Hypertension, Nephrology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only